How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →

Allay Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application to Initiate Pivotal Phase 2B Trial of ATX101 for the Treatment of Post-surgical Pain Following Total Knee Replacement Surgery

calendar_today June 12, 2024 person Chris Railey domain allay-therapeutics

Planned Phase 2b trial expected to enroll 200 participants at U.S. sites Study design and…